CCM
ZBH icon

Cinctive Capital Management’s Zimmer Biomet ZBH Stock Holding History

Cinctive Capital Management’s Portfolio ZBH Stock Details ZBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-50,000
Closed -$6.39M – 662
2022
Q1 		$6.39M Buy
+50,000
New +$6.03M 0.24% 144

Other funds holding ZBH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Cinctive Capital Management's ZBH Position: Q1 2025 in Review

Cinctive Capital Management sold out of Zimmer Biomet (ZBH) in Q1 2025, closing a stake of 41,773 shares — an estimated $4.41M sold.

Cinctive Capital Management first reported a position in ZBH in Q4 2019 and held it in 9 quarters. The position peaked at $14.7M in Q1 2021. 1,000 funds tracked by Wall St. Rank hold ZBH as of Q1 2025.

  • Cinctive Capital Management reported no remaining Zimmer Biomet position as of Q1 2025 after selling out during the quarter.
  • Cinctive Capital Management sold 41,773 Zimmer Biomet shares in Q1 2025, an estimated $4.41M.
  • Cinctive Capital Management first reported a position in Zimmer Biomet in Q4 2019 and held it in 9 quarters.
  • Cinctive Capital Management's Zimmer Biomet position peaked at $14.7M in Q1 2021.
  • 1,000 funds tracked by Wall St. Rank held Zimmer Biomet as of Q1 2025.

Based on Cinctive Capital Management's 13F filing for Q1 2025, filed 15 May 2025.